Mass spectrometry measurements of prostate-specific antigen (PSA) peptides derived from immune-extracted PSA provide a potential strategy for harmonizing immunoassay differences

American Journal of Clinical Pathology

Volumn 141, Issue 4, 2014, Pages 527-533

  Klee, Eric W ^a   Bondar, Olga P ^a   Goodmanson, Marcia K ^a   Trushin, Sergey A ^a   Singh, Ravinder J ^a   Leigh Anderson, N ^b   Klee, George G ^a  

^a Mayo Clinic   (United States)

^b The Plasma Proteome Institute   (United States)

Author keywords

Antisera; Harmonization; Immunoassay; Mass spectrometry; Peptides; PSA

Indexed keywords

PEPTIDE; PROSTATE SPECIFIC ANTIGEN; TRYPSIN; EPITOPE; PEPTIDE FRAGMENT;

ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; DIGESTION; EXTRACTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOASSAY; MALE; MASS SPECTROMETRY; PATIENT CARE; PRIORITY JOURNAL; AMINO ACID SEQUENCE; ANTISERA; BLOOD; CHEMISTRY; HARMONIZATION; IMMUNOLOGY; LIQUID CHROMATOGRAPHY; METABOLISM; METHODOLOGY; PSA; REPRODUCIBILITY; STANDARD; TANDEM MASS SPECTROMETRY;

ANTISERA; HARMONIZATION; IMMUNOASSAY; MASS SPECTROMETRY; PEPTIDES; PSA;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, LIQUID; EPITOPES; FEMALE; HUMANS; IMMUNOASSAY; MALE; PEPTIDE FRAGMENTS; PROSTATE-SPECIFIC ANTIGEN; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; TRYPSIN;

EID: 84899478287     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP8PEL0YXAHDVK     Document Type: Article

References (14)

1. Moyer VA, for the U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Internal Med. 2012;157:120-134.
2. Vesper HW, Thienpont LM. Traceability in laboratory medicine. Clin Chem. 2009;55:1067-1075.
3. Klee GG, Goodmanson MK, Jacobsen SJ, et al. Highly sensitive automated chemiluminometric assay for measuring free human glandular kallikrein-2. Clin Chem. 1999;45(pt 1):800-806. (Pubitemid 29266609)
4. Stenman UH, Paus E, Allard WJ, et al. Summary report of the TD-3 workshop: characterization of 83 antibodies against prostate-specific antigen. Tumour Biol. 1999;20(suppl 1):1-12.
5. Piironen T, Villoutreix BO, Becker C, et al. Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling. Protein Sci. 1998;7:259-269. (Pubitemid 28092846)
6. Leinonen J, Wu P, Stenman UH. Epitope mapping of antibodies against prostate-specific antigen with use of peptide libraries. Clin Chem. 2002;48:2208-2216. (Pubitemid 35397564)
7. Stephan C, Kopke T, Semjonow A, et al. Discordant total and free prostate-specific antigen (PSA) assays: does calibration with WHO reference materials diminish the problem? Clin Chem Lab Med. 2009;47:1325-1331.
8. Stephan C, Kahrs AM, Klotzek S, et al. Toward metrological traceability in the determination of prostate-specific antigen (PSA): calibrating Beckman Coulter Hybritech Access PSA assays to WHO standards compared with the traditional Hybritech standards. Clin Chem Lab Med. 2008;46:623-629. (Pubitemid 351749111)
9. Stephan C. Prostate cancer: WHO standardization of PSA tests: clinical consequences. Nat Rev Urol. 2009;6:303-305.
10. Kort SA, Martens F, Vanpoucke H, et al. Comparison of 6 automated assays for total and free prostate-specific antigen with special reference to their reactivity toward the WHO 96/670 reference preparation. Clin Chem. 2006;52:1568-1574. (Pubitemid 44148320)
11. Slev PR, La'ulu SL, Roberts WL. Intermethod differences in results for total PSA, free PSA, and percentage of free PSA. Am J Clin Pathol. 2008;129:952-958.
12. Forde JC, Marignol L, Blake O, et al. Standardization of assay methods reduces variability of total PSA measurements: an Irish study. BJU Int. 2012;110:644-650.
13. Schreiber WE, Endres DB, McDowell GA, et al. Comparison of fresh frozen serum to proficiency testing material in College of American Pathologists surveys: α-fetoprotein, carcinoembryonic antigen, human chorionic gonadotropin, and prostate-specific antigen. Arch Pathol Lab Med. 2005;129:331-337. (Pubitemid 40343987)
14. Stephan C, Klaas M, Muller C, et al. Interchangeability of measurements of total and free prostate-specific antigen in serum with 5 frequently used assay combinations: an update. Clin Chem. 2006;52:59-64. (Pubitemid 43032467)